Hinge Health CFO James Budge sells 35,907 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hinge Health, Inc. (HNGE) Chief Financial Officer James Budge reported direct sales of 35,907 Class A common shares on November 10, 2026, in five tranches: 1,900 at a weighted average price of $119.5214 per share, 7,601 at $120.6851, 15,899 at $121.3642, 4,925 at $122.7538, and 5,582 at $123.3433. The sales were made under a Rule 10b5-1 trading plan adopted June 11, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1, F2 | 1,900 | $119.5214 | $227K |
| Sale | Class A Common Stock F1, F3 | 7,601 | $120.6851 | $917K |
| Sale | Class A Common Stock F1, F4 | 15,899 | $121.3642 | $1.93M |
| Sale | Class A Common Stock F1, F5 | 4,925 | $122.7538 | $605K |
| Sale | Class A Common Stock F1, F6 | 5,582 | $123.3433 | $689K |
Footnotes (6)
- F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
- F2. Represents the weighted average sale price. The lowest price at which shares were sold was $119.00 and the highest price at which shares were sold was $119.92. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F3. Represents the weighted average sale price. The lowest price at which shares were sold was $120.05 and the highest price at which shares were sold was $121.04. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F4. Represents the weighted average sale price. The lowest price at which shares were sold was $121.05 and the highest price at which shares were sold was $122.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F5. Represents the weighted average sale price. The lowest price at which shares were sold was $122.11 and the highest price at which shares were sold was $123.10. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F6. Represents the weighted average sale price. The lowest price at which shares were sold was $123.11 and the highest price at which shares were sold was $123.77. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.